Navigation Links
Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls
Date:9/2/2009

ARMONK, N.Y., Sept. 2 /PRNewswire-FirstCall/ -- Implanet, a manufacturer of implantable medical devices, has selected IBM (NYSE: IBM) sensor technology as the foundation for BeepN'Track, a new service that traces the movement of Implanet's products - including knee and hip implants - across its supply chain to hospitals.

Spiraling medical costs and growing demand for medical care present the health care industry with unprecedented challenges. To meet the cost and quality expectations of the hospitals it serves, Implanet is infusing its operations with new intelligence to reduce the costs associated with human error, out-of-stock products, and supply chain inefficiencies while offering the best possible medical devices and supporting services.

By offering a line of products that are completely traceable, Implanet gives health care providers the peace of mind that comes with being able to easily identify patients whose implanted medical devices are the subject of a recall.

Prior to the creation of its new system, Implanet had no means of tracking its products once they left its manufacturing facilities. This meant the company's medical devices were difficult to trace once shipped.

The company's BeepN'Track service uses Radio Frequency Identification (RFID) tags to track medical devices from Implanet to hospitals. Prior to shipping, Implanet affixes an RFID tag bearing a unique serial number to the packaging of each individual device. Before a surgical procedure takes place, a hospital uses a handheld device to scan the tag from the medical device being implanted and stores that information along with the patient's records. The tag is given to the patient after surgery so he or she will have
'/>"/>

SOURCE IBM
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles
2. Researchers identify protein involved in causing gum disease, osteoporosis, arthritis
3. Summit VetPharm Helps Veterinarians Protect Against Product Diversion, Counterfeiting and Shrinkage Using Vectra(R) Bloodhound(R) Technology
4. Researchers identify new, cancer-causing role for protein
5. Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL
6. Business Association in Denver Invites Award-winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using the Color Red
7. Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials
8. Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
9. New Antibiotics May Target Cancer-Causing Proteins
10. Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup
11. Confusing New PBM Drug Pricing Terms Leave Payors Unsure of Next Steps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... California (PRWEB) , ... July 29, 2015 , ... Conventional ... sell, and trade goods and services may be able to unlock mysteries about the ... Claremont Graduate University , Boston University, and Columbia University. , The findings, published July ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... have become increasingly aware of the impact drinking and substance abuse is having ... illness. Financial loss is tagged in the billions per year. [1] Will Wesch, ...
(Date:7/29/2015)... ... ... Core Organizer ” was featured on NewsWatch as part of its monthly AppWatch, which ... Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the ... , Wouldn’t it be great if everyone could be a little more organized? Well ...
(Date:7/29/2015)... ... July 29, 2015 , ... More ... and service providers of children living with autism will converge upon Penn State ... demographic. , The National Autism Conference will be held Aug. 3-6 at ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... According to ... flies revealed a gene which is directly responsible for stimulating and perpetuating alcohol use ... in the journal entitled Proceedings of the National academy of Sciences, and has given ...
Breaking Medicine News(10 mins):Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Get More Organized with the Core Organizer App 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3
... , WASHINGTON, Aug. 31 As Congress prepares ... participating in at least 102 rallies and other events in ... a public health insurance option. , , ... the day Congress returns to Washington, D.C.. They are taking ...
... CHADDS FORD, Pa., Aug. 31 Endo Pharmaceuticals (Nasdaq: ENDP ) ... 2009 on Thursday, Sept. 10, 2009, at 2:40 p.m. EDT. Alan Levin, ... , , The presentation will be webcast live and can ... investors section. , , About Endo ...
... Aug. 31 A new study by Rand Corporation, published ... concludes retail clinics provide quality care at lower costs and ... study was based in part on data from MinuteClinic and ... to provide quality care and lower medical costs, MinuteClinic officials ...
... , , VENTURA, Calif., Aug. 31 ... than to receive." However, when the gift one is giving is ... with more than 97 percent organic aloe vera, receiving and giving ... Founded by Rinaldo and Lalla Brutoco, owners of the manufacturer ...
... , , , ... (the "Company") today announced that, at the Company,s 2009 Annual Meeting ... re-elect by an overwhelming majority all of the Company,s nominees to ... meeting were 63,725,589, representing approximately 56% of the 114,007,240 shares outstanding ...
... men, researchers say , MONDAY, Aug. 31 (HealthDay News) -- ... antigen (PSA) has led to mass over-diagnosis and over-treatment, a ... into use in 1986, federal government data show that the ... risen substantially, said the report in the Aug. 31 online ...
Cached Medicine News:Health News:'Let's Get it Done!' From Coast to Coast, USAction Affiliates Rally This Week for Quality, Affordable Health Care 2Health News:Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 2Health News:MinuteClinic Says Rand Corporation Study in Annals of Internal Medicine Study on Quality, Affordable Care at Retail Clinics Affirms Internal Information 2Health News:MinuteClinic Says Rand Corporation Study in Annals of Internal Medicine Study on Quality, Affordable Care at Retail Clinics Affirms Internal Information 3Health News:It's Better to Give Than to Receive 2Health News:It's Better to Give Than to Receive 3Health News:Healthcare Trust of America, Inc. Announces Results of 2009 Annual Meeting of Stockholders 2Health News:Healthcare Trust of America, Inc. Announces Results of 2009 Annual Meeting of Stockholders 3Health News:Prostate Cancer Over-Diagnosed: Study 2Health News:Prostate Cancer Over-Diagnosed: Study 3
(Date:7/29/2015)... Therapeutics (Nasdaq: NKTR ) will announce its financial results ... August 5, 2015, after the close of U.S.-based financial markets. ... host a conference call to review the results beginning at ... The press release and a live audio-only Webcast ... that is posted on the home page and Investor Relations ...
(Date:7/29/2015)... 29, 2015  Ascendis Pharma A/S (Nasdaq: ASND ... innovative TransCon technology to address significant unmet medical needs, ... on July 30, 2015, at 9:00 a.m. Eastern Time ... pediatric study of once-weekly TransCon Growth Hormone. The conference ... before the market opens on July 30, 2015. ...
(Date:7/29/2015)... 2015  STAAR Surgical Company (NASDAQ: STAA ), a ... systems for the eye today reported financial results for the ... Quarter Overview , Net Sales of $18.7 Million Down ... Impact of $2.1 Million from the Weakening Euro and Yen ... in China , APAC Sales Down 1% Including Korea ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3Ascendis Pharma A/S to Report Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone and Host Conference Call on Thursday, July 30, 2015 at 9:00 a.m. Eastern Time 2STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24
... Data from Phase 1 Clinical Trial of SNS-595 ... FRANCISCO, Calif., June 11, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, ... of the company's,anti-cancer product candidates, SNS-595 and SNS-032, ... (EHA) in Vienna,Austria. , Interim Results from Sunesis' ...
... 2007 (MARKET WIRE via COMTEX News Network),-- ... of Endo,Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), has ... placebo-controlled,clinical trial evaluating Frova (frovatriptan succinate) 2.5 ... women with,difficult-to-treat menstrual migraine (MM). The data ...
Cached Medicine Technology:Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7
Complete calibration kits are available for both pH and manometry systems....
... formulated buffers are available from ... antimony catheters. All buffers are ... internal or external reference, single ... are available in 250ml bottle ...
... formulated buffers are available from ... antimony catheters. All buffers are ... internal or external reference, single ... are available in 250ml bottle ...
Flexilog custom medical carts are configured to suite the requirements of FLEXILOG motility system users. With locking wheels and storage drawers, our carts are suitable for any care provider in any ...
Medicine Products: